Barton A. Kamen - Concepedia

Author

Barton A. Kamen

The University of Texas Southwestern Medical Center

Also Known As

B A Kamen, B KAMEN, BARTON A. KAMEN, BarTon A. Kamen, Barton A Kamen, Barton A. Kamen, Barton A. Kamen,, Barton Kamen, BartonA. Kamen

168

Publications

6.3K

Citations

H-Index

128

Concepts

All Affiliations

The University of Texas Southwestern Medical Center Rutgers, The State University of New Jersey Rutgers Cancer Institute Johnson University Pediatrics and Genetics

About

Barton A. Kamen is an author at The University of Texas Southwestern Medical Center specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	2.7K
2	Health Sciences	11	11	583
3	Natural Sciences	7	7	632
4	Engineering	1	1	106
5	Public Health	1	1	18

Barton A. Kamen

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development Jorge A. Piedrahita, Betty K. Oetama, Gregory D. Bennett, Nature Genetics Knockout MouseDevelopmental BiologyEarly Embryonic DevelopmentDevelopmental GeneticsGenetics	1999	370
Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Steven Weitman, Arthur G. Weinberg, Leslie R. Coney, PubMed Immunocytochemical TechniqueCellular LocalizationFolate HomeostasisPathologyCellular Pharmacology	1992	335
Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Leslie R. Coney, Antonella Tomassetti, Leon Carayannopoulos, PubMed Immunocytochemical TechniqueImmunologyGlycobiologyPathologyImmunotherapy	1991	299
Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: Association with hepatic folate deficiency and formation of polyglutamates Joel M. Kremer, John Galivan, Anita Streckfuss, Arthritis & Rheumatism	1986	214
Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate Ann M. Winter-Vann, Barton A. Kamen, Martin O. Bergö, Proceedings of the National Academy of Sciences Chemoprevention StrategyCancer BiologyOxidative StressMedicinal ChemistrySignaling Pathway	2003	145
DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY Richard A. Drachtman, Peter D. Cole, Carla Golden, Pediatric Hematology and Oncology Mtx TherapyPharmacological StudyIntrathecal MtxPharmacologyImmunology	2002	133
The folate receptor in central nervous system malignancies of childhood Steven Weitman, Karen M. Frazier, Barton A. Kamen Journal of Neuro-Oncology Neuro-oncologyFolate ReceptorMedicineInherited Metabolic DiseasePathology	1994	125
Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro Barton A. Kamen, Beatrice Eibl, Arlene R. Cashmore, Biochemical Pharmacology Hematological MalignancyMedicinal ChemistryOncologyNon-classical AntifolateHealth Sciences	1984	112
A rapid, radiochemical-ligand binding assay for methotrexate Barton A. Kamen, Patricia L. Takach, Radka Vatev, Analytical Biochemistry EngineeringRadiochemical-ligand Binding AssayRadioanalytical ChemistryRadiopharmaceutical TherapyAnalytical Chemistry	1976	106
Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model Jan B. Wollack, Benedette Makori, Stuti Ahlawat, Journal of Neurochemistry Cell CultureCell ProliferationCellular PhysiologyOxidative StressMetabolic Signaling	2007	91

Page 1